| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/16/2005 | WO2004050013A3 Material compositions and related systems and methods for treating cardiac conditions |
| 06/16/2005 | WO2004048565A9 Apoptosis-associated protein and use thereof |
| 06/16/2005 | WO2004047855A3 Proteins involved in the regulation of energy homeostasis |
| 06/16/2005 | WO2004037195A3 Treatment of diabetes |
| 06/16/2005 | WO2004033642A3 Alpha 2hs glycoprotein for treatment of cancer and a method for preparation thereof |
| 06/16/2005 | WO2003091390A3 Regulation of gene expression by neuromodulators and discovery of a novel ngf-induced protein termed pincher |
| 06/16/2005 | WO2003012072A3 Monoclonal antibodies to activated erbb family members and methods of use thereof |
| 06/16/2005 | WO2003006621A3 Super osteocalcin promoter for the treatment of calcified tumors and tissues |
| 06/16/2005 | WO2000053621A3 Synthetic complementary peptides and ophthalmologic uses thereof |
| 06/16/2005 | WO1990004979A8 Method of preventing or reducing eosinophilia |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131647 Calculating confidence levels for peptide and protein identification |
| 06/16/2005 | US20050131221 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 06/16/2005 | US20050131218 Used to study cellular processes such as immune regulation, cell proliferation, cell death, and inflammatory responses |
| 06/16/2005 | US20050131212 Neurogenic peptide for use in enhancement of neuronal migration, proliferation, survival, differentiation, and/or neurite outgrowth |
| 06/16/2005 | US20050131210 Genes and proteins, and their use |
| 06/16/2005 | US20050131064 Administering powder or aerosol to nasal mucous membrane |
| 06/16/2005 | US20050131062 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |
| 06/16/2005 | US20050130929 For introduction of a disc prosthesis or implant; involves providing substance(s) beneficial to the intervertebral disc through a cannulated element |
| 06/16/2005 | US20050130927 For treating neoplasm, hypoproliferation, hyperproliferation, degenerative and neurodegenerative diseases, ischaemia, immune system disorder, infectious disease, or metabolic dysfunction |
| 06/16/2005 | US20050130926 Drug screening; cancer diagnosis; host cells |
| 06/16/2005 | US20050130925 Transduction; prostaglandins E1 (PGE1); introducing a recombinant cDNA encoding at least one cyclooxygenase isoform into the cells such that cells overexpress cyclooxygenase isoform then treating cells with fatty acid substrate |
| 06/16/2005 | US20050130924 Reducing amounts of a selected wild-type mRNA target within a cell, by binding to the mRNA target an antisense compound; treating or preventing a disease or condition associated with a preselected target cellular protein in an animal |
| 06/16/2005 | US20050130916 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 06/16/2005 | US20050130915 Polymorphic antiviral nucleoside compounds |
| 06/16/2005 | US20050130914 Methods of administering dalbavancin for treatment of skin and soft tissue infections |
| 06/16/2005 | US20050130909 Gram-positive bacterial infection of skin and soft tissue; soluble |
| 06/16/2005 | US20050130907 N,N'-bis(halophenethyl)aminoalkylamide compounds of given formula as novel pain relievers for cancer or neuropathic pain, or use in cosmetic aftershave or after-sun product; works by inhibiting the vanilloid receptors and show a marginal activity on the NMDA receptor and the neuronal calcium channels |
| 06/16/2005 | US20050130906 Amelioration of macular degeneration and other ophthalmic diseases |
| 06/16/2005 | US20050130905 Extended storage of reduced glutathione solutions |
| 06/16/2005 | US20050130904 Therapeutic compositions |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
| 06/16/2005 | US20050130901 Having antimicrobial activity |
| 06/16/2005 | US20050130900 Sustained release drug formulations containing a carrier peptide |
| 06/16/2005 | US20050130898 Carboxypeptidase R inhibiting peptide |
| 06/16/2005 | US20050130897 Diabetes, chronic inflammation, brain edema, edema, arthritis, uvietis, ascites, macular edema, cancer, hyperglycemia, kidney inflammation and other kidney disorders; kallistatin |
| 06/16/2005 | US20050130896 Methods and compostions for inhibiting intracellular aggregate formation |
| 06/16/2005 | US20050130895 Radiolabelled shiga-like toxins as ANTITUMOR AGENTS for treating ovarian, breast, and brain tumors; imaging a tumor in a mammal |
| 06/16/2005 | US20050130894 In sows and gilts by a single injection of a gonadotropin releasing hormone, a luteinizing hormone, and/or human chorionic gonadotropin, or derivatives or analogues to stimulate ovarian follicle ovulation; and breeding |
| 06/16/2005 | US20050130893 eg DADLE which is [D-Ala2-D-Leu5]enkephalin acetate (Tyr-D-Ala-Gly-Phe-D-Leu), deltorphin D; heat stroke |
| 06/16/2005 | US20050130892 B-cell activation factor for use in diagnosis, prevention and treatment of glomerulonephritis and autoimmune diseases |
| 06/16/2005 | US20050130891 Containing at least two of the following active substances A, B, C, wherein: A=at least one hormone stimulating the production of cAMP; B=at least one substance inhibiting the degradation of a cyclic nucleotide; C=at least one hormone stimulating the production of cGMP |
| 06/16/2005 | US20050130889 Analog further comprises an amino acid substitution wherein the cysteine residue at BPI amino acid position 132 is replaced by another amino acid; for treating gram-negative bacterial infections in a subject; bactericidal for gram-positive bacteria and mycoplasma; enhances effectiveness of antibiotics |
| 06/16/2005 | US20050130888 Use of metallothionein as an active ingredient in effecting and enhancing recovery of damaged neuronal tissue, particularly following physical trauma and damage thereto |
| 06/16/2005 | US20050130887 Method of diagnosis and detection of potential carriers of mutated gene, bone related diseases; gene therapy recombinant technology and therapy using information derived from the DNA, protein and the function of the protein |
| 06/16/2005 | US20050130884 Pharmacologically active antiviral peptides and methods of their use |
| 06/16/2005 | US20050130883 Serine protease inhibitors |
| 06/16/2005 | US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 06/16/2005 | US20050130880 zinc(II) organic complex with ligands selected from aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, alpha - and beta -hydroxycarboxylic acids, vitamins, glutamine; insulin mimetics; less toxic; |
| 06/16/2005 | US20050130879 Modifying tissue surfaces by liquid crystal formation |
| 06/16/2005 | US20050130878 Prevention of photic injury by administering a TACE inhibitor |
| 06/16/2005 | US20050130877 Axon regeneration with PKC inhibitors |
| 06/16/2005 | US20050130876 Use of substances for treating tumors |
| 06/16/2005 | US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 06/16/2005 | US20050130301 Using centrifugation to separate and isolate buffy coat and platelet rich fractions of blood/bone marrow sample; tissue engineering and regenerative medicine |
| 06/16/2005 | US20050130287 Purifying process of soluble proteins of the l.obliqua bristles through prothrombin activation: process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction II, n-terminal and internal fragments sequences |
| 06/16/2005 | US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders |
| 06/16/2005 | US20050130285 Reference solution |
| 06/16/2005 | US20050130271 Method of suppressing differentiation by administering a human serrate-1 polypeptide |
| 06/16/2005 | US20050130268 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs; host cell |
| 06/16/2005 | US20050130265 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 06/16/2005 | US20050130242 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 06/16/2005 | US20050130233 Using enhanced neurotrophin-3 expression/activity as diagnostic/prognostic indicator of nervous system disorders |
| 06/16/2005 | US20050130209 Expression vector comprising nucleotide sequences coding deoxyribonuclease for use as tool in treatment and prevention of cystic fibrosis |
| 06/16/2005 | US20050130206 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis |
| 06/16/2005 | US20050130204 Protein-transport-associated molecules |
| 06/16/2005 | US20050130189 Using chromic visceral hypersensitivity (CVH) polypeptide concentration as diagnostic tool in detection of inflammatory disorders |
| 06/16/2005 | US20050130181 RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA) |
| 06/16/2005 | US20050130166 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050130132 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 06/16/2005 | US20050130130 Killer cell activatory receptor ligand for use in diagnosis, prevention and treatment of infection, cell proliferative, autoimmune and arthritic disorders |
| 06/16/2005 | US20050130128 Methods for detecting NEBR1 expression in a biological sample by contacting a sample with the labeled antibody; inhibits HIV replication in host cells |
| 06/16/2005 | US20050130127 Coronavirus-like particles comprising functionally deleted genomes |
| 06/16/2005 | US20050129747 Crosslinking polyoxyalkylene glycol as oxygen carrier; diabetic tissue degradation |
| 06/16/2005 | US20050129740 Process for inhibition of proteolytic activity during the ensiling of forages |
| 06/16/2005 | US20050129731 Polysulfone coating containing antiproliferative agents, antiinflammatory agents; antiphlogistic agent, anticoagulants; stents for prevent restenosis |
| 06/16/2005 | US20050129727 Drug core encapsulated with multilayer polyelectrolyte shells |
| 06/16/2005 | US20050129724 Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions |
| 06/16/2005 | US20050129723 Skin care composition that mediates cell to cell communication |
| 06/16/2005 | US20050129718 Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant |
| 06/16/2005 | US20050129717 Novel uses |
| 06/16/2005 | US20050129716 Therapeutic use of botulinum toxins types A and B |
| 06/16/2005 | US20050129706 Bonded to polyethylene glycol through a linking group, wherein the arginine deiminase is derived from Streptococcus, Borrelia, Giardia, Clostridium, Enterococcus, Lactobacillus, or Bacillus; improved tumoricidal activity; anticarcinogenic, antitumor, antimetastasis agents; melanoma |
| 06/16/2005 | US20050129702 Tick chitinase |
| 06/16/2005 | US20050129700 comprises antibodies against Smallpox Inhibitor of Complement Enzyme (SPICE) or Vaccinia Virus Complement Control Protein (VCP); dna vaccines |
| 06/16/2005 | US20050129698 Polypeptides (MBP1) capable of interacting with oncogenic mutants of the p53 protein |
| 06/16/2005 | US20050129697 Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides |
| 06/16/2005 | US20050129693 Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders |
| 06/16/2005 | US20050129688 Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants |
| 06/16/2005 | US20050129685 Use of IL-1 blockers to prevent corneal inflammation and neovascularization |
| 06/16/2005 | US20050129683 Human testis expressed patched like protein |
| 06/16/2005 | US20050129682 Receptor for Advanced Glycation Endproducts (RAGE); rheumatoid arthritis; solubility |
| 06/16/2005 | US20050129681 Inhibiting endothelial cell adhesion and migration; limit specific binding of integrin alpha 4 beta 1; antitumor |
| 06/16/2005 | US20050129677 Altering the degree of internalization of the toxin; preventing or treating botulinum toxin intoxication; treating metabolic disorders, muscular disorders, nervous system disorders, and/or pain conditions |
| 06/16/2005 | US20050129676 Compounds and methods for modulating functions of classical cadherins |
| 06/16/2005 | US20050129675 Methods for treatment of acute pancreatitis |
| 06/16/2005 | US20050129670 Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor |